The Global Cancer Conference 2016 and '50 for 50' initiative
The International Agency for Research on Cancer (IARC) was founded on 20 May 1965. [2] For the past 50 years, the IARC has served as the specialised cancer research unit of the World Health Organization. The IARC strives to promote international collaboration in cancer research. [5] Celebrating the 50th year of its existence, the IARC held a conference in Lyon on 7 -10 June 2016, where almost 1 000 scientists from across the globe came together to discuss today's cancer-related challenges and tomorrow's agenda for cancer prevention. [6] The programme was characterised by distinguished speakers, including Freddie Bray and Graham Colditz. There were themed parallel sessions on 'epidemiology' , 'mechanisms' and 'prevention and mortality reduction' and panel debates and more than 300 posters were presented. [4] (reproduced with permission from the IARC). Embedded in this celebration, the IARC hosted the '50 for 50' initiative. Fifty future cancer research leaders from 40 LMICs were identified, one for each year of the agency's existence. The IARC enabled these researchers to participate in a specialised, 2-day preconference workshop (entitled Fostering Leadership in Cancer Research) and to attend the conference on Global Cancer: Occurrence, Causes, and Avenues to Prevention. Fostering of leadership in cancer research was undertaken through four highly interactive sessions on: (i) infrastructure needs for a cancer research group/institution/centre; (ii) networking in research; (iii) safeguarding the integrity of research and research participants; and (iv) funding. Modules were presented by a dynamic IARC team and opportunities to meet IARC scientists were created. IARC director Christopher Wild engaged regularly with the group. During the conference, Lynette Denny (University of Cape Town) was a receipent of the 2016 IARC Medal of Honour for her research on cervical cancer in Africa. There was a special session on the social determinants of health, led by Prof. Sir Michael Marmot.
Fig. 1. Global distribution of estimated age-standardised (world) cancer incidence rates per 100 000, for all sites combined (excluding non-melanoma skin cancer) in (A) men and (B) women, 2012
We learned that the burden of cancer is expected to double over the next 20 years. Young cancer researchers have an important role to play, and we believe that we are up for the challenge. [4] (reproduced with permission from the IARC).
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